rs10090395

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001142446.2(ANK1):​c.127-51219A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 152,156 control chromosomes in the GnomAD database, including 7,011 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 7011 hom., cov: 33)

Consequence

ANK1
NM_001142446.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.36

Publications

1 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.418 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001142446.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_001142446.2
c.127-51219A>G
intron
N/ANP_001135918.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000265709.14
TSL:1
c.127-51219A>G
intron
N/AENSP00000265709.8
ANK1
ENST00000705521.1
c.127-51219A>G
intron
N/AENSP00000516136.1

Frequencies

GnomAD3 genomes
AF:
0.293
AC:
44549
AN:
152036
Hom.:
7003
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.426
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.377
Gnomad FIN
AF:
0.215
Gnomad MID
AF:
0.433
Gnomad NFE
AF:
0.327
Gnomad OTH
AF:
0.342
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.293
AC:
44560
AN:
152156
Hom.:
7011
Cov.:
33
AF XY:
0.291
AC XY:
21621
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.210
AC:
8726
AN:
41494
American (AMR)
AF:
0.426
AC:
6523
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1255
AN:
3472
East Asian (EAS)
AF:
0.116
AC:
602
AN:
5188
South Asian (SAS)
AF:
0.378
AC:
1821
AN:
4814
European-Finnish (FIN)
AF:
0.215
AC:
2282
AN:
10590
Middle Eastern (MID)
AF:
0.428
AC:
125
AN:
292
European-Non Finnish (NFE)
AF:
0.327
AC:
22256
AN:
67992
Other (OTH)
AF:
0.342
AC:
721
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1621
3241
4862
6482
8103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.315
Hom.:
3261
Bravo
AF:
0.306
Asia WGS
AF:
0.249
AC:
865
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.058
DANN
Benign
0.30
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10090395; hg19: chr8-41666874; API